HI
AIM

Harbour Investments’s AIM ImmunoTech AIM Stock Holding History

Harbour Investments’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Hold
32
– – ﹤0.01% 4741
2026
Q1 		$19 Buy
+32
New +$32 ﹤0.01% 4626
2025
Q4 		– Sell
-10
Closed -$27 – 4055
2025
Q3 		$27 Hold
10
– – ﹤0.01% 3702
2025
Q2 		$87 Hold
10
– – ﹤0.01% 3527
2025
Q1 		$122 Buy
+10
New +$161 ﹤0.01% 3457

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Harbour Investments's AIM Position: Q2 2026 in Review

Harbour Investments held its AIM ImmunoTech (AIM) position steady in Q2 2026 at 32 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #4741.

Harbour Investments first reported a position in AIM in Q1 2025 and has held it in 5 quarters since. The position peaked at $122 in Q1 2025. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Harbour Investments held 32 shares of AIM ImmunoTech worth $9 as of Q2 2026.
  • Harbour Investments left its AIM ImmunoTech share count unchanged in Q2 2026.
  • AIM ImmunoTech made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4741 holding.
  • Harbour Investments first reported a position in AIM ImmunoTech in Q1 2025 and has held it in 5 quarters since.
  • Harbour Investments's AIM ImmunoTech position peaked at $122 in Q1 2025.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.